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ABSTRACT 
Background: Little is known about joint effects of maternal asthma and maternal depression on 
childhood asthma. 
Objective: To examine whether maternal depression and maternal asthma lead to greater risk of 
childhood asthma than maternal asthma alone.  
Methods: Cross-sectional studies of children (ages 6-14 years) in San Juan, Puerto Rico (n=655) 
and Sweden (n=6,887). In Puerto Rico, maternal depressive symptoms were defined using the 
Center for Epidemiologic Studies Depression Scale (CES-D) questionnaire. In Sweden, maternal 
physician-diagnosed depression was derived from national registries, and maternal depressive 
symptoms were defined using an abbreviated CES-D questionnaire. Childhood asthma was 
defined as physician-diagnosed asthma, plus current wheeze (in Puerto Rico) or medication use 
(in Sweden). Logistic regression was used for the multivariable analysis.  
Results: Compared to Puerto Rican children whose mothers had neither asthma nor depressive 
symptoms, those whose mothers had asthma but no depressive symptoms had 3.2 times 
increased odds of asthma (95% confidence interval [CI]=2.1-4.8), and those whose mothers had 
both asthma and depressive symptoms had 6.5 times increased odds of asthma (95% CI=3.3-
13.0). Similar results were obtained for maternal depression and maternal asthma in the Swedish 
cohort (odds ratio [OR] for maternal asthma without maternal depression= 2.8, 95% CI=2.1-3.7; 
OR for maternal asthma and maternal depression=4.0, 95% CI=1.7-9.6). Although the estimated 
effect of maternal asthma on childhood asthma was increased when maternal depressive 
symptoms (Puerto Rico) or maternal depression (Sweden) was present, there were no statistically 
significant additive interactions.    
Conclusion: Maternal depression may further increase the risk of asthma in children with 
maternal history of asthma. 
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INTRODUCTION 1 
Asthma is the most common chronic disease of childhood and a major public health problem in 2 
the United States (U.S.) and worldwide (1, 2). In the U.S., the burden of childhood asthma is 3 
unequally distributed across racial or ethnic groups, with Puerto Ricans and non-Hispanic Blacks 4 
being more affected with this disease than non-Hispanic whites or Mexican Americans (3). In  5 
Nordic countries, including Sweden, the incidence of childhood asthma increased until the 6 
1990s, and then reached a plateau in the 2000s (4).  7 
 8 
Depression is a common mental illness that affects 8-16% of women of reproductive age (5). 9 
Depression is frequent during and after pregnancy, affecting 10-15% of all gravid and post-10 
partum mothers (6, 7) Among Hispanics, Puerto Rican mothers have twice the risk of mental 11 
health disorders (including depression) as Mexican Americans (8). In large studies of adults, 12 
depression has been associated with asthma (9, 10). 13 
 14 
The high frequency of comorbid depression and asthma in women of reproductive age may 15 
increase the risk of childhood asthma. Maternal depression may affect asthma in pre-school and 16 
school-aged children through indirect mechanisms, including second-hand smoke and non-17 
adherence to prescribed controller medications. If present during pregnancy, maternal depression 18 
has been associated with increased odds of wheeze (an asthma symptom) from ages 1 to 4 years 19 
(odds ratio [OR]=1.5, 95% confidence interval [CI]=1.2-1.8)(11), with one study suggesting a 20 
dose-response relationship between maternal depressive symptoms and severity of childhood 21 
wheeze (12). 22 
 23 
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Maternal history of asthma is one of the strongest risk factors for childhood asthma. Children 24 
born to mothers with a history of asthma have up to fivefold higher odds of asthma than those 25 
born to mothers without history of asthma (95% CI for OR=1.7-14.9) (13). 26 
 27 
Even though depression and asthma are common in women of reproductive age (1, 14-17), no 28 
study has assessed whether maternal depressive symptoms or maternal depression accentuates 29 
the detrimental effects of maternal asthma on childhood asthma. We hypothesized that maternal 30 
depressive symptoms or maternal depression further increases the risk of asthma in children 31 
whose mothers have asthma. We examined this hypothesis using two different study populations, 32 
first in a cohort of Puerto Rican children living in San Juan, Puerto Rico, and then in a cohort of 33 
Swedish children. By replicating the study in two populations that differ with regard to genetics, 34 
environmental exposures and socioeconomic factors, cultural practices, and diet, we hoped to 35 
reduce false positive findings and confounding bias.  36 
 37 
METHODS 38 
Puerto Rican Cohort 39 
Subject Recruitment 40 
Details on study design and subject recruitment have been previously reported (18, 19). In brief, 41 
from March 2009 to June 2010, children were chosen from randomly selected households in the 42 
metropolitan area of San Juan (Puerto Rico), using a multistage probability design. Primary 43 
sampling units were randomly selected neighborhood clusters based on the 2000 U.S. Census, 44 
and secondary sampling units were randomly selected houses within each primary sampling unit.  45 
A household was eligible if ≥1 resident was a child aged 6 to 14 years old. In households with >1 46 
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eligible child, only one child was randomly selected for screening. On the basis of the sampling 47 
design, 7,073 households were selected and 6,401 (90.5%) were contacted. Of these 6,401 48 
households, 1,111 had ≥1 child within the age range of the study who met other eligibility 49 
criterion (see below). In an effort to reach a target sample size of ~700 children (which would 50 
give us ≥90% power to detect an OR ≥2 for exposures with a prevalence ≥25%), we attempted to 51 
enroll a random sample (n=783) of these 1,111 children. Parents of 105 of these 783 eligible 52 
households refused to participate or could not be reached. There were no significant differences 53 
in age, gender, or area of residence between eligible children who did (n=678 [86.6%]) and did 54 
not (n=105 [13.4%]) agree to participate.  55 
 56 
The main recruitment tool was a screening questionnaire given to parents of children ages 6 to 14 57 
years to obtain information about the child’s general and respiratory health. We selected as cases 58 
children with parental report of physician-diagnosed asthma and wheeze in the previous year. 59 
We selected as control subjects children who had neither parental report of physician-diagnosed 60 
asthma nor wheeze in the prior year. All participants had to have four Puerto Rican grandparents, 61 
to ensure their Puerto Rican descent. Of the 678 study participants, 655 (~97%) had complete 62 
information on maternal depressive symptoms and were included in the current analysis.    63 
 64 
Study Procedures 65 
Study participants completed a protocol that included administration of questionnaires, and 66 
measurement of height and weight. One of the child’s parents (usually [>93%] the mother) 67 
completed a questionnaire that was slightly modified from the one used in the Collaborative 68 
Study of the Genetics of Asthma (20). This questionnaire was used to obtain information about 69 
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the child’s general and respiratory health, socio-demographic characteristics, and family history.  70 
In children, asthma was defined as physician-diagnosed asthma and wheeze in the previous year.  71 
Maternal history of asthma was defined as a positive answer to the question: “Has the child’s 72 
mother ever had asthma?” Maternal depressive symptoms were assessed using the Center for 73 
Epidemiologic Studies Depression Scale (CESD), a 20-item questionnaire that has been widely 74 
used and validated for epidemiologic studies in the general population.(21, 22) The overall 75 
CESD score is calculated by summing the scores for each item, and ranges from 0 to 60 points.  76 
Maternal depressive symptoms were considered present if the CESD score was ≥ 21 points, an 77 
adequate cutoff score for significant depressive symptoms in Puerto Rican adults, and an 78 
indicator of severe depressive symptoms in non-Puerto Rican adults (21, 22).  79 
 80 
Written parental consent was obtained for participating children, from whom written assent was 81 
also obtained. The study was approved by the Institutional Review Boards of the University of 82 
Puerto Rico (San Juan, PR; protocol #0160507), Brigham and Women’s Hospital 83 
(Boston, MA; protocol #2007-P-001174/9), and the University of Pittsburgh (Pittsburgh, PA; 84 
protocol #PRO-10030498). 85 
 86 
Statistical Analysis 87 
We used two-sample t-tests to compare pairs of binary and continuous variables, and chi squared 88 
tests for comparison of binary variables. A stepwise approach was used to build the multivariable 89 
logistic regression models of maternal depressive symptoms, maternal asthma and childhood 90 
asthma. Because of their well-established association with depression and/or asthma, all final 91 
models included age, gender (23), household income (< vs. ≥ $15,000/year [near the median 92 
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income for households in Puerto Rico in 2008-2009 ])(24-26) and early-life exposure (in utero or 93 
in the first two years of life) to environmental tobacco smoke (ETS) (27). Other covariates 94 
considered in the initial multivariate models included body mass index (BMI) as a z-score (based 95 
on 2000 CDC growth charts) and current exposure to ETS; these covariates were removed from 96 
the final models, as they were neither associated with asthma at P<0.05 nor changed the 97 
parameter estimate (β) for maternal depressive symptoms by ≥10%. After the final multivariable 98 
models were built, we tested for a first-order interaction (on a multiplicative scale) between 99 
maternal depressive symptoms and maternal asthma on childhood asthma. Next, we examined 100 
the odds of childhood asthma in four subgroups: 1) no maternal asthma and no maternal 101 
depressive symptoms, 2) no maternal asthma but maternal depressive symptoms, 3) maternal 102 
asthma but no maternal depressive symptoms, and 4) both maternal asthma and depressive 103 
symptoms. Additive interactions were then examined using the Relative Excess Risk due to 104 
Interaction (RERI)(28). 105 
 106 
All statistical analyses were performed with SAS version 9.4 software (SAS Institute, Cary, NC). 107 
 108 
Swedish Cohort  109 
Subject Recruitment 110 
The Study of Twin Adults: Genes and Environment (STAGE) study population was derived 111 
from the Swedish Twin Registry (STR). During 2005-2006, all twins born between 1959 and 112 
1985 were invited to participate in an extensive telephone interview or web-based questionnaire 113 
on habits, diseases, diet, living conditions and work (29). Children who were aged 6-14 years 114 
during 2005-2006 and had a mother in the STAGE cohort were eligible for this analysis. 115 
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Children of twins were identified using the Swedish Multi-Generation register. Adopted children 116 
were excluded, as were parents who emigrated after completing the questionnaire. In total, 117 
25,383 twins (59.6%) responded to the questionnaire. Registry data were available for 24,685 118 
twins: 15,720 of these had 32,561 biological children. After applying the eligibility and 119 
exclusion criteria, 6,887 children were included in the current analysis. 120 
 121 
Study Procedures 122 
Study participants completed questionnaires as part of the STAGE and Swedish Multi-123 
Generation Registry. Maternal physician-diagnosed depression was defined as a diagnosis of 124 
depression from a hospital or outpatient clinic, derived from the Swedish Patient register (PAR) 125 
from 2005-2010. The ICD-10 diagnoses codes included: F32.0-F32.3, F32.8, F32.9, F33.1-126 
F33.4, F33.8, F33.9, F34.1, and F41.2. Maternal depressive symptoms were measured using the 127 
previously validated eleven-item Iowa short version of the CES-D, an index of self-reported 128 
depressive symptoms in the last week (30). We allowed up to two missing items, and the scores 129 
of these two items were calculated using imputation of the mean of the individual’s response to 130 
the non-missing items of the scale. Each item gives a score of 0-3 points, for a maximum 131 
possible total score of 33 points. A score larger than 8 was classified as depressive symptoms 132 
(30, 31). Maternal asthma was self-reported asthma in the STAGE questionnaire, defined as a 133 
positive answer to the question “Do you have asthma?”  Early exposure (in utero) to ETS was 134 
derived from the MBR, and determined during pregnancy by midwives asking mothers about 135 
their smoking status at the first antenatal visit. Socio-economic status, defined as the highest 136 
educational attainment of the mother at the time of the STAGE questionnaire, was taken from the 137 
Swedish Longitudinal integration database for health insurance and labor (LISA) register.  138 
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 139 
In children, asthma was derived using PAR and the Swedish Prescribed Drug Registers (SPDR) 140 
between 2005 and 2010. Asthma was defined as an asthma diagnosis (ICD code J45 or J46) in 141 
the PAR, AND/OR: 1) any asthma medication except β2- agonist dispensed at least twice from 142 
July 2005, or 2) any asthma medication dispensed at least thrice during one calendar year from 143 
2006-2010, identified with the Anatomical Therapeutic Chemical (ATC) codes R03BA (inhaled 144 
corticosteroids), R03AK (fixed combinations of β2-agonist and corticosteroids), R03DC 145 
(leukotriene receptor antagonists) or R03AC (β2- agonist). Dispensed asthma medication from 146 
the SPDR and register-based asthma diagnoses in PAR are suitable proxies for an asthma 147 
diagnosis (32). 148 
 149 
Permission for the study was obtained from the Regional Ethical Review board in Stockholm, 150 
Sweden. 151 
 152 
 153 
 154 
Statistical Analysis 155 
Logistic regression was used for the multivariable analysis of maternal physician-diagnosed 156 
depression (heretofore called “maternal depression”, for ease of exposition) or maternal 157 
depressive symptoms, maternal asthma and childhood asthma, using a similar approach to that 158 
used for the Puerto Rican cohort. All models were adjusted for offspring age, gender, early 159 
exposure to ETS and maternal educational level. All analyses used robust standard errors to 160 
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account for clustering of observations within twin pairs. Statistical analyses were conducted 161 
using Stata release 14.1 (Stata Corp, College Station, TX, USA). 162 
 163 
RESULTS 164 
Table 1 shows the main characteristics of the Puerto Rican (n=655) and Swedish (n=6,887) 165 
study participants. In the Puerto Rican cohort, children with asthma (cases) were significantly 166 
younger and more likely to be male, to have been exposed to ETS, to have a maternal history of 167 
asthma, and to have a mother with depressive symptoms. There were no significant differences 168 
in household income or maternal education between cases and control subjects.  169 
In the Swedish cohort, those with asthma (cases) were more likely to be male and to have a 170 
maternal history of asthma. There were no significant differences in maternal education, early or 171 
current ETS, maternal depression or maternal depressive symptoms between children with and 172 
without asthma. By design, the age of study participants was similar across study cohorts. 173 
Compared with cases in the Swedish cohort, those in the Puerto Rican cohort were more likely to 174 
be exposed to ETS, and to have a maternal history of asthma. 175 
 176 
Table 2 shows the results of the analysis of maternal depressive symptoms and asthma among 177 
Puerto Rican children. In the unadjusted analysis, maternal depressive symptoms were 178 
significantly associated with 1.4 times increased odds of childhood asthma. After adjustment for 179 
age, gender, household income, and early-life ETS, maternal depressive symptoms remained 180 
significantly associated with 1.5 times increased odds of childhood asthma (Model 1). After 181 
additional adjustment for maternal asthma, the association between maternal depressive 182 
symptoms and childhood asthma was nearly unchanged in magnitude but became non-183 
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statistically significant (P=0.05, Model 2). We found no significant interaction between maternal 184 
depressive symptoms and maternal asthma on childhood asthma in a multiplicative scale (P= 0.3, 185 
tested in Model 2). 186 
 187 
Figure 1 shows the proportion of children with asthma in four subgroups of Puerto Rican and 188 
Swedish children, classified according to the presence of maternal asthma and maternal 189 
depressive symptoms or maternal depression. In Puerto Rico, 40% of children with no maternal 190 
asthma and no maternal depressive symptoms had asthma, and 81% of those with maternal 191 
asthma and maternal depressive symptoms had asthma (Figure 1A). In Sweden, 6% of children 192 
with no maternal asthma and no maternal depression had asthma, and 18% of those with both 193 
maternal asthma and maternal depression had asthma (Figure 1B).  194 
 195 
Given the results shown above and our a priori hypothesis, we next examined the relation 196 
between categories of maternal depressive symptoms and maternal asthma, and asthma in Puerto 197 
Rican children (Table 3). Compared with children without maternal asthma or maternal 198 
depressive symptoms, those with maternal asthma had 3.1 times significantly increased odds of 199 
asthma, and those with both maternal asthma and maternal depressive symptoms had 6.4 times 200 
significantly increased odds of asthma. Maternal depressive symptoms were not significantly 201 
associated with childhood asthma in the absence of maternal asthma. Nearly identical findings 202 
were obtained in a multivariable analysis. In this analysis, the RERI between maternal asthma 203 
and maternal depression was positive (and thus suggestive of an additive interaction), but not 204 
statistically significant (3.0, 95% CI= -1.4 to 7.4).  205 
 206 
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Table 3 shows the results of the unadjusted and adjusted analyses of categories of maternal 207 
asthma and maternal depression, and asthma in Swedish children. Consistent with our findings in 208 
Puerto Rico, maternal depression was not significantly associated with childhood asthma in the 209 
absence of maternal asthma.  In a multivariable analysis, maternal asthma was significantly 210 
associated with 2.8 times increased odds of childhood asthma in the absence of maternal 211 
depression. In this analysis, maternal asthma was significantly associated with 4.0 times 212 
increased odds of childhood asthma in the presence of maternal depression.  In the multivariable 213 
model, the estimated RERI was positive, but not statistically significant for an additive 214 
interaction between maternal asthma and maternal depression (1.5, 95% CI= -1.0, 4.0). As in 215 
Puerto Rico, there was no significant interaction between maternal asthma and maternal 216 
depression on a multiplicative scale. 217 
 218 
Supplementary Table 1 shows the results of the unadjusted and adjusted analyses of categories 219 
of maternal asthma and maternal depressive symptoms, and asthma in Swedish children. 220 
Compared with children without maternal depressive symptoms or maternal asthma, those with 221 
maternal asthma had threefold significantly increased odds of asthma, and those with maternal 222 
asthma and maternal depressive symptoms also had threefold significantly increased odds of 223 
asthma. Similar results were obtained in a multivariable analysis. In this analysis, maternal 224 
depression alone was not significantly associated with childhood asthma. Consistent with no 225 
additive interaction, the estimated RERI was not significant (-0.24, 95% CI= -1.27 to 0.80). 226 
 227 
DISCUSSION 228 
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Among Puerto Ricans, we show that maternal depressive symptoms are not significantly 229 
associated with asthma in children without maternal history of asthma, but that the association 230 
between maternal asthma and childhood asthma appears stronger when maternal depressive 231 
symptoms are present (aOR=6.5) than when such maternal symptoms are absent (aOR=3.3). 232 
Consistent with our findings in Puerto Ricans, maternal physician-diagnosed depression was not 233 
significantly associated with asthma in Swedish children without maternal history of asthma. 234 
However, the association between maternal asthma and asthma in Swedish children seems 235 
stronger when maternal depression is present (aOR=4.0) than when maternal depression is absent 236 
(aOR=2.8). In contrast to findings for maternal depression (which indicates more severe 237 
depressive symptoms), the association between maternal asthma and asthma in Swedish children 238 
was similar in the presence or absence of maternal depressive symptoms. Although we found no 239 
statistically significant additive or multiplicative interaction between maternal asthma and 240 
maternal depressive symptoms or maternal depression in Puerto Ricans or Swedes, we had 241 
limited statistical power to detect such an interaction.   242 
 243 
Our negative results for an association between maternal depressive symptoms or maternal 244 
depression and asthma in the absence of maternal asthma differ from those in an Australian 245 
study, which reported an association between maternal depressive symptoms and asthma in 246 
children ages 6 to 7 years old, regardless of maternal history of asthma (33). In addition to 247 
differences in geographic location and the race or ethnicity of study participants, the Australian 248 
study examined repeated measures of depressive symptoms between the first year of life and 249 
school-age, which we lacked. To our knowledge, however, this is the first report of potential 250 
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joint detrimental effects of maternal asthma and maternal depressive symptoms or maternal 251 
depression in school-aged children. 252 
 253 
Several plausible mechanisms could explain a particularly strong association between maternal 254 
asthma and childhood asthma in the presence of maternal depressive symptoms (in Puerto Rico) 255 
or maternal depression (in Sweden). Depressive symptoms or clinical depression may alter the 256 
mother’s ability to care for her children. Maternal depression could thus influence asthma in 257 
children through poor healthcare utilization or reduced adherence to controller medications (34). 258 
Moreover, parental mental illness has been linked to poor asthma management in children, 259 
leading to increased risk of hospitalization (35). Maternal depression in caregivers has been 260 
associated with increased asthma morbidity in children in some studies (36) but not in others 261 
(10). Alternatively, some of the women with asthma and depressive symptoms or clinical 262 
depression may have been depressed during pregnancy, and perinatal stressors may increase the 263 
risk of childhood asthma by altering immune responses (37) or the hypothalamic-pituitary-264 
adrenal (HPA) axis (35). However, we cannot test this hypothesis in our cross-sectional study. 265 
 266 
Maternal asthma has been a strong risk factor for childhood asthma in cross-sectional (38) and 267 
birth cohort studies (13, 37), which have estimated ORs for maternal asthma ranging between 3.3 268 
and 5.0. Consistent with those findings, we found that maternal asthma was associated with 3.5 269 
times increased odds of asthma in Puerto Rican children, and with 2.7-2.8 times increased odds 270 
of asthma among Swedish children. Our results extend those from prior studies, and suggest that 271 
maternal depressive symptoms or maternal depression increases the risk of childhood asthma 272 
conferred by maternal asthma alone. 273 
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Our study has several strengths, including replication in two ethnically divergent populations 274 
living in markedly different geographic locations and thus exposed to different environments, 275 
and ability to account for confounding factors (including gender, household income and early-276 
life ETS). However, we recognize several study limitations. First, maternal depression was 277 
assessed 6 to 14 years after the birth of study participants, and thus we cannot assess the role of 278 
prenatal or perinatal depression, or treatment of maternal depression, on childhood asthma. 279 
Second, we used a cutoff score of 21 points for depressive symptoms, based on our prior work in 280 
Puerto Rican adults, instead of a cutoff score of 16 points (used in non-Puerto Rican women). 281 
However, we obtained similar results using a cutoff score of 16 points (data not shown), and a 282 
cutoff score of 21 points has been previously used to indicate more severe depressive symptoms 283 
in non-Puerto Rican women (40, 41).  Maternal asthma was associated with similarly increased 284 
odds of asthma in Swedish children regardless of concurrent depressive symptoms, but we 285 
observed a difference in the magnitude of the association between maternal asthma and asthma 286 
between Swedish children who did and did not have a mother with physician-diagnosed 287 
depression (a marker of more severe depressive symptoms), albeit smaller than that found in the 288 
Puerto Rican cohort.  289 
 290 
In summary, our findings suggest that maternal depressive symptoms (in Puerto Rico) or 291 
maternal depression (in Sweden) further increases the risk of asthma among children with a 292 
maternal history of asthma. Our results need confirmation in longitudinal studies with adequate 293 
statistical power to detect additive interactions between maternal asthma and maternal 294 
depression. Such studies should help further elucidate whether maternal depression (during or 295 
after pregnancy) interacts with maternal asthma on the pathogenesis of childhood asthma.    296 
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Table 1: Main characteristics of study participants  
 Puerto Rico Sweden 
 Controls  
(n=314) 
Cases 
(n=341) 
Controls 
(n=6,401) 
Cases 
(n=486) 
Age (years) 10.9 (2.7) 10.4 (2.6) ‡ 9.84 (2.6) 10.2 (2.6) ‡ 
Male gender 153 (48.7 %) 194 (56.9 %) ‡ 3225 (50.4%) 307 (63.2%) § 
Early-life environmental tobacco smoke*   122 (38.8 %) 168 (49.3 %) § 629 (9.8%) 44 (9.1%) 
Current environmental tobacco smoke 107 (34.1 %) 152 (44.6 %) § 1545 (24.1%) 128 (26.3%) 
Household income >$15,000 per year 110 (36.7 %) 116 (34.6 %) -- -- 
Maternal education      
Middle school only 99 (31.5 %) 108 (31.7 %) 337 (5.3%) 25 (5.1%) 
High school graduate 91 (29.0 %) 96 (28.2 %) 3089 (48.3%) 235 (48.4%) 
Less than 3 years of college 56 (17.8 %) 55 (16.1 %) 1133 (17.7%) 91 (18.7%) 
3 or more years of college  68 (21.7 %) 82 (24.1 %) 1793 (28%) 135 (27.8%) 
Maternal asthma  66 (21.0 %) 166 (48.7 %) § 600 (9.4%) 108 (22.2%) § 
Maternal depression     
Depressive symptoms**   67 (21.3 %) 96 (28.2 %) ‡ 1937 (30.3%) 169 (34.8%) 
Physician-diagnosed depression   154 (2.4%) 14 (2.9%) 
Data are presented as mean (SDs) for continuous variables or number (percentage) for binary variables.   
*Early-life environmental tobacco smoke: In utero or before age 2 years. 
**Depressive symptoms: A full Center for Epidemiologic Studies Depression (CESD) score ≥ 21 points in Puerto Rico, or an abbreviated CESD score >8  
    points (in Sweden) 
‡P-value <0.05 for the comparison between cases and controls at each location 
§P-value <0.01 for the comparison between cases and controls at each location 
Table 2: Maternal depressive symptoms and asthma among participating children in Puerto Rico  
 Unadjusted Model  1* Model 2* 
 Odds ratio (95% confidence interval), P value 
Maternal depressive symptoms  1.4 (1.0-2.1), 0.04 1.5 (1.0-2.2), 0.04 1.5 (1.0-2.2), 0.05 
    
Age (years)  0.9 (0.9-1.0), 0.02 0.9 (0.9-1.0), 0.01 
    
Male gender  1.4 (1.0-1.9), 0.05 1.5 (1.1-2.1), 0.02 
    
Household income >$15,000/year  1.2 (0.8-1.6), 0.42 1.2 (0.8-1.7), 0.37 
    
Early-life environmental tobacco 
smoke 
 1.6 (1.1-2.2), 0.01 1.5 (1.1-2.1), 0.02 
    
Maternal asthma       3.5 (2.5-5.1), <0.001 
Maternal depressive symptoms: A Center for Epidemiologic Studies Depression (CESD) score ≥ 21 points. Early-life ETS (environmental tobacco smoke):  
  In utero or before age 2 years 
    *Model 1 was adjusted for age, gender, household income, and early-life ETS. Model 2 was additionally adjusted for maternal asthma. 
 
 
 
 
 
 
 
 
 
 
  
Table 3: Analysis of categories of maternal asthma and maternal depressive symptoms, and  
asthma among participating children in Puerto Rico and Sweden (STAGE) 
 Maternal history of: Unadjusted Adjusted 
 Asthma Depressive symptoms^ Odds ratio, 95% confidence interval, P value 
Puerto Rico No No 1.0 1.0 
 No Yes 1.2 (0.8-1.9) 1.3 (0.8-2.1) 
 Yes No 3.1 (2.1-4.6) 3.2 (2.1-4.8) 
 Yes Yes   6.4 (3.3-12.4)    6.5 (3.3-12.9) 
 Asthma Physician-diagnosed 
depression 
 
Odds ratio (95% confidence interval), P value 
Sweden No No 1.0 1.0 
 No Yes 0.6 (0.2-1.5) 0.4 (0.1-1.3) 
 Yes No 2.7 (2.1-3.5) 2.8 (2.1-3.7) 
 Yes Yes 3.3 (1.4-7.8) 4.0 (1.7-9.6) 
 
^Depressive symptoms: A Center for Epidemiologic Studies Depression (CESD) score ≥ 21 points   
*Adjusted for age, gender, household income and early-life (in utero or before age 2 years) environmental tobacco smoke  
